Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Neurochemistry International
|
May 28, 2010
Comparative properties of the dopamine transport complex in dog and rodent brain: striatal [(3)H]GBR12935 binding and [(3)H]dopamine uptake
N A Sharif, J L Nunes, A D Michel, et al.
British Journal of Pharmacology
|
August 2, 2006
Investigation of the prostacyclin (IP) receptor antagonist RO1138452 on isolated blood vessel and platelet preparations
R L Jones, H Wise, R Clark, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
July 1, 1991
Characterization of muscarinic receptors mediating release of epithelial derived relaxant factor (EpDRF) in guinea-pig isolated trachea
R M Eglen, G C Harris, M Taylor, et al.
British Journal of Pharmacology
|
October 1, 1989
The interaction of hexamethonium with muscarinic receptor subtypes in vitro
R M Eglen, A D Michel, C M Cornett, et al.
Neurochemical Research
|
February 1, 1995
Quantitative autoradiography demonstrates selective modulation of rat brain regional dopamine (D1 and D2) receptor subtypes after chronic manipulation of dietary salt
N A Sharif, J L Nunes, R P Rosenkranz, et al.
British Journal of Pharmacology
|
August 1, 1989
The pharmacological properties of the peptide, endothelin
R M Eglen, A D Michel, N A Sharif, et al.
British Journal of Pharmacology
|
December 1, 1988
The interaction of methoctramine and himbacine at atrial, smooth muscle and endothelial muscarinic receptors in vitro
R M Eglen, W W Montgomery, I A Dainty, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 1, 1992
Characterization of the interaction of the cervane alkaloid, imperialine, at muscarinic receptors in vitro
R M Eglen, G C Harris, H Cox, et al.
Journal of Cardiovascular Pharmacology
|
June 26, 1998
Cardiovascular effects of nepicastat (RS-25560-197), a novel dopamine beta-hydroxylase inhibitor
W C Stanley, K Lee, L G Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1993
RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo
R M Eglen, C H Lee, W L Smith, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Neurochemistry International
|
May 28, 2010
Comparative properties of the dopamine transport complex in dog and rodent brain: striatal [(3)H]GBR12935 binding and [(3)H]dopamine uptake
N A Sharif, J L Nunes, A D Michel, et al.
British Journal of Pharmacology
|
August 2, 2006
Investigation of the prostacyclin (IP) receptor antagonist RO1138452 on isolated blood vessel and platelet preparations
R L Jones, H Wise, R Clark, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
July 1, 1991
Characterization of muscarinic receptors mediating release of epithelial derived relaxant factor (EpDRF) in guinea-pig isolated trachea
R M Eglen, G C Harris, M Taylor, et al.
British Journal of Pharmacology
|
October 1, 1989
The interaction of hexamethonium with muscarinic receptor subtypes in vitro
R M Eglen, A D Michel, C M Cornett, et al.
Neurochemical Research
|
February 1, 1995
Quantitative autoradiography demonstrates selective modulation of rat brain regional dopamine (D1 and D2) receptor subtypes after chronic manipulation of dietary salt
N A Sharif, J L Nunes, R P Rosenkranz, et al.
British Journal of Pharmacology
|
August 1, 1989
The pharmacological properties of the peptide, endothelin
R M Eglen, A D Michel, N A Sharif, et al.
British Journal of Pharmacology
|
December 1, 1988
The interaction of methoctramine and himbacine at atrial, smooth muscle and endothelial muscarinic receptors in vitro
R M Eglen, W W Montgomery, I A Dainty, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 1, 1992
Characterization of the interaction of the cervane alkaloid, imperialine, at muscarinic receptors in vitro
R M Eglen, G C Harris, H Cox, et al.
Journal of Cardiovascular Pharmacology
|
June 26, 1998
Cardiovascular effects of nepicastat (RS-25560-197), a novel dopamine beta-hydroxylase inhibitor
W C Stanley, K Lee, L G Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1993
RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo
R M Eglen, C H Lee, W L Smith, et al.
Page
of 9